IXL DIABETES MANAGEMENT SYSTEM— 510(k) K031373

Name: FDA 510(k) clearance K031373
Creator: U.S. Food and Drug Administration
Published: 2003-12-19

Substantially Equivalent

Insulet Corp.

FDA 510(k) clearance K031373 for IXL DIABETES MANAGEMENT SYSTEM, Substantially Equivalent on 2003-12-19. Applicant: Insulet Corp.. Device class: 2.

Clearance details

Applicant: Insulet Corp.
Product code: Code LZG
Device class: Class 2
Regulation: 21 CFR 880.5725
Advisory panel: General Hospital
Date received: 2003-04-30
Decision date: 2003-12-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Beverly, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LZG

view all

K262153 — Pivot Insulin Delivery System2026-09-02
K253534 — Pivot Insulin Delivery System2026-04-08
K240158 — Modular Medical MODD1 Insulin Delivery System2024-09-04
K241622 — Extended Reservoir; MiniMed Reservoir2024-07-02
K223372 — Omnipod GO Insulin Delivery Device2023-04-24

Adverse events under product code LZG

product code LZG

Death: 104
Injury: 12,022
Malfunction: 135,004
Other: 1
Total: 147,131

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.